348 related articles for article (PubMed ID: 7590880)
1. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma inhibits CD44-hyaluronan interactions in normal human B lymphocytes.
Kryworuchko M; Diaz-Mitoma F; Kumar A
Exp Cell Res; 1999 Jul; 250(1):241-52. PubMed ID: 10388538
[TBL] [Abstract][Full Text] [Related]
5. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
6. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions.
Rousset F; Billaud M; Blanchard D; Figdor C; Lenoir GM; Spits H; De Vries JE
J Immunol; 1989 Sep; 143(5):1490-8. PubMed ID: 2547869
[TBL] [Abstract][Full Text] [Related]
7. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line BL30/B95-8 and in Epstein-Barr virus (EBV) transformed human B cells: loss of IL-13 receptors on Burkitt's lymphoma B cells.
Gee K; Kozlowski M; Kryworuchko M; Diaz-Mitoma F; Kumar A
Cell Immunol; 2001 Aug; 211(2):131-42. PubMed ID: 11591117
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
[TBL] [Abstract][Full Text] [Related]
10. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
11. The alternative splicing of human Fc gamma RII mRNA is regulated by activation of B cells with mIgM cross-linking, interleukin-4, or phorbolester.
Sármay G; Rozsnyay Z; Koncz G; Danilkovich A; Gergely J
Eur J Immunol; 1995 Jan; 25(1):262-8. PubMed ID: 7843241
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
13. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
[TBL] [Abstract][Full Text] [Related]
14. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
[TBL] [Abstract][Full Text] [Related]
17. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
Weber B; Rösel M; Arch R; Möller P; Zöller M
Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925
[TBL] [Abstract][Full Text] [Related]
18. CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus.
Zhang RD; Henderson EE
Virology; 1994 Feb; 198(2):709-13. PubMed ID: 7507284
[TBL] [Abstract][Full Text] [Related]
19. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
20. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
